Completed PHASE3 Interventional NCT00047424
Stop Atherosclerosis in Native Diabetics Study (SANDS)
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Interventions
ACE inhibitors simvastatin
Updated 2 times since 2017 Last updated: Feb 4, 2009
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This PHASE3 trial investigates Atherosclerosis and Cardiovascular Diseases and is currently completed. National Heart, Lung, and Blood Institute (NHLBI) leads this study, which shows 2 recorded versions since 2026 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
2 versions recorded-
Jun 2018 — Present [monthly]
Completed PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- National Heart, Lung, and Blood Institute (NHLBI)
Data source: National Heart, Lung, and Blood Institute (NHLBI)
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.